General Information About Pain After A Fracture Pain is the body’s natural response when a bone breaks. Both the fracture and any injuries to the body tissue near the fracture […]

We are aware of recent media reports that long-term use of bisphosphonates for osteoporosis (sold under the names of Fosamax [alendronate] and Actonel [risedronate]) may be associated with the occurrence […]

On January 18, 2023, INOVAIT and the Government of Canada announced a major investment in the field of image-guided therapy (IGT).

The Canadian Musculoskeletal Conference 2023 is designed for family physicians, bone health specialists, as well as allied health professionals interested in bone health. The conference offers an advanced medical education […]

A number of recent medical reports have linked high doses of intravenous bisphosphonates given to patients for the treatment of multiple myeloma, breast cancer or other cancers, to a condition […]

No link between the use of bisphosphonates and the risk of cancer of the esophagus or stomach has also been noted in a recent large study from the UK. This […]

Horizon Health Network’sDr. Everett Chalmers Regional Hospital Horizon Health Network’s Dr. Everett Chalmers Regional Hospital Brookfield Chair in Fracture Prevention Funds New Fracture Liaison Service (FLS) Program in Fredericton, NB […]

On behalf of Osteoporosis Canada’s Scientific Advisory Consultants and Osteoporosis Canada, we would like to announce this year’s Lindy Fraser Award winner as chosen by the members of the SAC. […]

After rigorous peer review, the Michael Smith Foundation for Health Research (MSFHR) recently awarded the Fraser Health Authority team in British Columbia (BC), a three-year project team grant worth $500,000. […]